CONGRUENCE
LIVE

Serial Number

79397307

Owner

Congruence Therapeutics Inc.

Attorney

Kelsey A. Cloud

Filing Date

May 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CONGRUENCE Trademark

Serial Number: 79397307 • Registration: 7830578

CONGRUENCE is a trademark filed by Congruence Therapeutics Inc. on May 2, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Congruence Therapeutics Inc. (3 trademarks)

7171 Rue Frederick-Banting

Entity Type: 99

Trademark Details

Filing Date

May 2, 2024

Registration Date

June 17, 2025

Published for Opposition

April 29, 2025

Goods & Services

Scientific and medical research.

Providing information relating to medical disorders, diagnosis and treatment options.

Pharmaceutical preparations for treating rare diseases, metabolic diseases, and neurodegenerative diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 16, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 16, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 30, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 12, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 17, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 17, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2025 TROA
REFUSAL PROCESSED BY IB
Dec 21, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 2, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 2, 2024 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 22, 2024 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 17, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 16, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 16, 2024 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2024 NREP
APPLICATION FILING RECEIPT MAILED
Jun 18, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 13, 2024 REPR